← FDA Drug Approvals (Drugs@FDA)

TRUSELTIQ

NDA · New Drug Application · Sponsor: HELSINN HLTHCARE · Approved 2021-05-28

Drug application

FDA Application #

NDA214622

Application type

New Drug Application

Brand name

TRUSELTIQ

Generic name

Infigratinib Phosphate

Active ingredients

INFIGRATINIB PHOSPHATE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Discontinued

Sponsor

HELSINN HLTHCARE

First approval

2021-05-28

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown